Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Loss of Nf1 and Ink4a/Arf Are Associated with Sex-Dependent Growth Differences in a Mouse Model of Embryonal Rhabdomyosarcoma.
Curr Issues Mol Biol. 2023 Feb 2;45(2):1218-1232. doi: 10.3390/cimb45020080.
Curr Issues Mol Biol. 2023.
PMID: 36826025
Free PMC article.
Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models.
Gutierrez WR, Scherer A, McGivney GR, Brockman QR, Knepper-Adrian V, Laverty EA, Roughton GA, Dodd RD.
Gutierrez WR, et al. Among authors: brockman qr.
Sci Rep. 2021 Jan 13;11(1):1098. doi: 10.1038/s41598-020-80216-1.
Sci Rep. 2021.
PMID: 33441747
Free PMC article.
Item in Clipboard
Epigenetic modulation in sensitizing metastatic sarcomas to therapies and overcoming resistance.
Rytlewski J, Brockman QR, Dodd RD, Milhem M, Monga V.
Rytlewski J, et al. Among authors: brockman qr.
Cancer Drug Resist. 2022 Jan 4;5(1):25-35. doi: 10.20517/cdr.2021.88. eCollection 2022.
Cancer Drug Resist. 2022.
PMID: 35582536
Free PMC article.
Item in Clipboard
PRC2 loss drives MPNST metastasis and matrix remodeling.
Brockman QR, Scherer A, McGivney GR, Gutierrez WR, Voigt AP, Isaacson AL, Laverty EA, Roughton G, Knepper-Adrian V, Darbro B, Tanas MR, Stipp CS, Dodd RD.
Brockman QR, et al.
JCI Insight. 2022 Oct 24;7(20):e157502. doi: 10.1172/jci.insight.157502.
JCI Insight. 2022.
PMID: 36066973
Free PMC article.
Item in Clipboard
Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanism.
Gutierrez WR, Scherer A, Rytlewski JD, Laverty EA, Sheehan AP, McGivney GR, Brockman QR, Knepper-Adrian V, Roughton GA, Quelle DE, Gordon DJ, Monga V, Dodd RD.
Gutierrez WR, et al. Among authors: brockman qr.
JCI Insight. 2022 Nov 22;7(22):e159419. doi: 10.1172/jci.insight.159419.
JCI Insight. 2022.
PMID: 36227698
Free PMC article.
Item in Clipboard
CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.
Kohlmeyer JL, Lingo JJ, Kaemmer CA, Scherer A, Warrier A, Voigt E, Raygoza Garay JA, McGivney GR, Brockman QR, Tang A, Calizo A, Pollard K, Zhang X, Hirbe AC, Pratilas CA, Leidinger M, Breheny P, Chimenti MS, Sieren JC, Monga V, Tanas MR, Meyerholz DK, Darbro BW, Dodd RD, Quelle DE.
Kohlmeyer JL, et al. Among authors: brockman qr.
Clin Cancer Res. 2023 Sep 1;29(17):3484-3497. doi: 10.1158/1078-0432.CCR-23-0749.
Clin Cancer Res. 2023.
PMID: 37410426
Free PMC article.
Item in Clipboard
Discrepancies in indel software resolution with somatic CRISPR/Cas9 tumorigenesis models.
Brockman QR, Scherer A, McGivney GR, Gutierrez WR, Rytlewski J, Sheehan A, Warrier A, Laverty EA, Roughton G, Carnevale NC, Knepper-Adrian V, Dodd RD.
Brockman QR, et al.
Sci Rep. 2023 Sep 8;13(1):14798. doi: 10.1038/s41598-023-41109-1.
Sci Rep. 2023.
PMID: 37684258
Free PMC article.
Item in Clipboard
Chimeric antigen receptor T cell therapies for multiple myeloma.
Wu C, Zhang L, Brockman QR, Zhan F, Chen L.
Wu C, et al. Among authors: brockman qr.
J Hematol Oncol. 2019 Nov 21;12(1):120. doi: 10.1186/s13045-019-0823-5.
J Hematol Oncol. 2019.
PMID: 31752943
Free PMC article.
Review.
Item in Clipboard
Cite
Cite